Brief: Vtv Therapeutics Gets Notice From Hangzhou Zhongmei Huadong Pharmaceutical Of Intent To Terminate License Agreement Dated Dec 21,2017
22/12/2023 21:54
Dec 22 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS-ON DEC 18,VTV LLC GOT NOTICE FROM
HANGZHOU
ZHONGMEI HUADONG PHARMACEUTICAL OF INTENT TO TERMINATE LICENSE
AGREEMENT DATED DEC 21,2017
* VTV THERAPEUTICS INC: TERMINATION OF AGREEMENT WILL NOT BE
EFFECTIVE UNTIL AFTER BOTH PARTIES NEGOTIATE AND FINALIZE A
TERMINATION AGREEMENT
* VTV THERAPEUTICS INC: IN ITS NOTICE TO CO, HUADONG
INDICATED
THAT IT HAD DECIDED TO DISCONTINUE FURTHER DEVELOPMENT OF TTP273
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)